WallStreetZenWallStreetZen

NASDAQ: SRPT
Sarepta Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SRPT

Based on 11 analysts offering 12 month price targets for Sarepta Therapeutics Inc.
Min Forecast
$80.00-1.57%
Avg Forecast
$145.64+79.18%
Max Forecast
$224.00+175.59%

Should I buy or sell SRPT stock?

Based on 11 analysts offering ratings for Sarepta Therapeutics Inc.
Buy
Strong Buy
5 analysts 45.45%
Buy
3 analysts 27.27%
Hold
3 analysts 27.27%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SRPT stock forecasts and price targets.

SRPT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-21
lockedlocked$00.00+00.00%2023-11-21
lockedlocked$00.00+00.00%2023-11-02
lockedlocked$00.00+00.00%2023-11-02
lockedlocked$00.00+00.00%2023-11-02
JP Morgan
Bottom 4%
4
Strong BuyMaintains$115.00+41.49%2023-10-31
Morgan Stanley
Bottom 2%
2
Strong BuyMaintains$146.00+79.63%2023-10-31
Mizuho
Bottom 2%
2
Strong BuyReiterates$160.00+96.85%2023-09-26
Goldman Sachs
Top 27%
74
Strong BuyMaintains$215.00+164.52%2023-06-23
Credit Suisse
Bottom 1%
1
HoldReiterates$141.00+73.47%2023-06-23

1 of 2

Forecast return on equity

Is SRPT forecast to generate an efficient return?
Company
N/A
Industry
-0.68%
Market
30.08%

Forecast return on assets

Is SRPT forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.19%

SRPT revenue forecast

What is SRPT's revenue in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$1.2B+9.96%
Avg 2 year Forecast
$1.7B+55.41%
Avg 3 year Forecast
$2.3B+105.74%
SRPT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SRPT revenue growth forecast

How is SRPT forecast to perform vs Biotechnology companies and vs the US market?
Company
27%
Industry
33.88%
Market
7.51%
SRPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SRPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SRPT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SRPT$81.28$145.64+79.18%Buy
ROIV$9.56$16.21+69.60%Strong Buy
JAZZ$118.23$191.29+61.79%Buy
IMGN$29.35$23.03-21.54%Strong Buy
KRTX$191.21$261.64+36.83%Strong Buy
View Top Biotech Stocks

Sarepta Therapeutics Stock Forecast FAQ

Is Sarepta Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: SRPT) stock is to Buy SRPT stock.

Out of 11 analysts, 5 (45.45%) are recommending SRPT as a Strong Buy, 3 (27.27%) are recommending SRPT as a Buy, 3 (27.27%) are recommending SRPT as a Hold, 0 (0%) are recommending SRPT as a Sell, and 0 (0%) are recommending SRPT as a Strong Sell.

If you're new to stock investing, here's how to buy Sarepta Therapeutics stock.

What is SRPT's revenue growth forecast for 2023-2025?

(NASDAQ: SRPT) Sarepta Therapeutics's forecast annual revenue growth rate of 27% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.88%, and while it is forecast to beat the US market's average forecast revenue growth rate of 7.51%.

Sarepta Therapeutics's revenue in 2023 is $1,104,982,000.On average, 8 Wall Street analysts forecast SRPT's revenue for 2023 to be $113,667,543,070, with the lowest SRPT revenue forecast at $110,925,128,569, and the highest SRPT revenue forecast at $117,111,089,944. On average, 8 Wall Street analysts forecast SRPT's revenue for 2024 to be $160,647,060,455, with the lowest SRPT revenue forecast at $132,836,287,020, and the highest SRPT revenue forecast at $193,923,205,180.

In 2025, SRPT is forecast to generate $212,665,750,452 in revenue, with the lowest revenue forecast at $141,678,319,308 and the highest revenue forecast at $276,754,113,871.

What is SRPT's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: SRPT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.19%.

What is SRPT's Price Target?

According to 11 Wall Street analysts that have issued a 1 year SRPT price target, the average SRPT price target is $145.64, with the highest SRPT stock price forecast at $224.00 and the lowest SRPT stock price forecast at $80.00.

On average, Wall Street analysts predict that Sarepta Therapeutics's share price could reach $145.64 by Nov 21, 2024. The average Sarepta Therapeutics stock price prediction forecasts a potential upside of 79.18% from the current SRPT share price of $81.28.

What is SRPT's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: SRPT) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.